The inflammatory bowel disease (IBD) is incurable, chronic, recrudescent disorders in the
inflamed intestines. Current clinic treatments are challenged by systemic exposure-induced …

Colorectal cancer (CRC), one of the most common and deadliest diseases worldwide, poses
a great health threat and social burden. The clinical treatments of CRC encompassing …

Anti-inflammatory drugs targeting inflammatory bowel disease (IBD) have attracted
considerable attention but still face low therapeutic outcomes and frequent side effects …

The co-delivery of curcumin (CUR) with other polyphenol bioactives often has synergistic
benefits. However, conventional co-encapsulation carriers formed by precipitation frequently …

Background Nanomedicine presents a promising alternative for cancer treatment owing to
its outstanding features. However, the therapeutic outcome is still severely compromised by …

Inflammatory bowel diseases (IBD) and colorectal cancer (CRC) are difficult to cure, and
available treatment is associated with troubling side effects. In addition, current therapies …

Tendon regeneration is greatly influenced by the oxidant and the inflammatory
microenvironment. Persistent inflammation during the tendon repair can cause matrix …

Excessive generation of reactive oxygen species (ROS) resulting in oxidative stress and
plays a crucial role in the progression of inflammatory bowel disease (IBD), which may in …